Composition
- Active ingredients
- METHYLPREDNISOLONE SODIUM SUCCINATE EQ 1GM BASE/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- METHYLPREDNISOLONE SODIUM SUCCINATE EQ 500MG BASE/VIAL · InjectableANDA089173-001 · Discontinued
- METHYLPREDNISOLONE SODIUM SUCCINATE EQ 40MG BASE/VIAL · InjectableANDA040664-001 · Discontinued
- METHYLPREDNISOLONE SODIUM SUCCINATE EQ 500MG BASE/VIAL · InjectableANDA089575-001 · Discontinued
- METHYLPREDNISOLONE SODIUM SUCCINATE EQ 40MG BASE/VIAL · InjectableANDA040793-001 · Discontinued
- METHYLPREDNISOLONE SODIUM SUCCINATE EQ 125MG BASE/VIAL · InjectableANDA085855-001 · Discontinued
- METHYLPREDNISOLONE SODIUM SUCCINATE EQ 1GM BASE/VIAL · InjectableANDA089576-001 · Discontinued
- METHYLPREDNISOLONE SODIUM SUCCINATE EQ 1GM BASE/VIAL · InjectableThis page
- METHYLPREDNISOLONE SODIUM SUCCINATE EQ 40MG BASE/VIAL · InjectableANDA085853-001 · Discontinued
- METHYLPREDNISOLONE SODIUM SUCCINATE EQ 1GM BASE/VIAL · InjectableANDA089174-001 · Discontinued
- METHYLPREDNISOLONE SODIUM SUCCINATE EQ 125MG BASE/VIAL · InjectableANDA040665-001 · Discontinued
- METHYLPREDNISOLONE SODIUM SUCCINATE EQ 125MG BASE/VIAL · Injectable
At a glance
- Brand name
- A-Methapred
- Active substance
- methylprednisolone sodium succinate
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Hospira
- Status
- Discontinued
- FDA approval
- 28 Mar 1978
- Application
- ANDA085852-001